Susan G. Kim
CIK 1825421 · View on SEC EDGAR ↗
First SEC filing: Sept. 30, 2020 · Latest: Sept. 30, 2020
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2024 | PACB | S | 19,782 | $1.72 | $34,025 | 695,654 Direct | -2.77% | Disposed | -24.7% (price as of 2026-08-20) |
| March 4, 2024 | PACB | S | 5,275 | $4.87 | $25,689 | 712,260 Direct | -0.74% | Disposed | -73.4% (price as of 2026-08-20) |
| Feb. 20, 2024 | PACB | S | 831 | $5.26 | $4,371 | 282,758 Direct | -0.29% | Disposed | -75.4% (price as of 2026-08-20) |
| Feb. 16, 2024 | PACB | S | 22,496 | $5.96 | $134,076 | 283,589 Direct | -7.35% | Disposed | -78.3% (price as of 2026-08-20) |
| Sept. 29, 2023 | PACB | S | 19,257 | $8.44 | $162,529 | 306,085 Direct | -5.92% | Disposed | -84.7% (price as of 2026-08-20) |
| March 3, 2023 | PACB | S | 5,045 | $9.49 | $47,877 | 323,505 Direct | -1.54% | Disposed | -86.4% (price as of 2026-08-20) |
| Feb. 17, 2023 | PACB | S | 907 | $10.27 | $9,315 | 162,581 Direct | -0.55% | Disposed | -87.4% (price as of 2026-08-20) |
| Sept. 29, 2022 | PACB | S | 12,968 | $5.61 | $72,750 | 163,488 Direct | -7.35% | Disposed | -76.9% (price as of 2026-08-20) |
| Feb. 17, 2022 | PACB | S | 1,062 | $11.06 | $11,746 | 134,966 Direct | -0.78% | Disposed | -88.3% (price as of 2026-08-20) |
| Sept. 29, 2021 | PACB | S | 20,272 | $25.75 | $522,004 | 136,028 Direct | -12.97% | Disposed | -95.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 2, 2022 | PACB | Stock Option (right to buy) | Common Stock (239,000) | $11.70 | March 2, 2032 | 239,000 | Acquired |
| Feb. 16, 2021 | PACB | Stock Option (right to buy) | Common Stock (12,600) | $46.37 | Feb. 16, 2031 | 12,600 | Acquired |
| Sept. 28, 2020 | PACB | Stock Option (right to buy) | Common Stock (400,000) | $9.60 | Sept. 28, 2030 | 400,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $449,743 | — | $2,219,710 | — | — | — | — | $2,669,453 |
| 2023 | $457,167 | — | $1,832,108 | — | $230,000 | — | — | $2,519,275 |
| 2022 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.